Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Bronchogenic × cemiplimab × Clear all

Sponsor

Conditions

Recurrence 3 Melanoma 3 Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Cutaneous Squamous Cell Carcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Advanced Non-Small Cell Lung Carcinoma 1 Adenocarcinoma 1

Interventions

pralsetinib 2 Pemetrexed 2 Carboplatin 2 selpercatinib 1 pembrolizumab 1 durvalumab 1 atezolizumab 1 alectinib 1 Tyrosine Kinase Inhibitors 1 Radiosurgery 1 Paclitaxel 1 Gemcitabine 1 Dasatinib 1 Cisplatin 1 Bevacizumab 1 Afatinib 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡